Cargando…
Long-Term Outcomes of C3 Glomerulopathy and Immune-Complex Membranoproliferative Glomerulonephritis in Children
INTRODUCTION: The reclassification of membranoproliferative glomerulonephritis (MPGN) into immune-complex MPGN (IC-MPGN) and C3 glomerulopathy (C3G) has provided insights into 2 distinct diseases. Although outcomes in adults are poor in both diseases, the pediatric literature is scarce and limited t...
Autores principales: | Kirpalani, Amrit, Jawa, Natasha, Smoyer, William E., Licht, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710848/ https://www.ncbi.nlm.nih.gov/pubmed/33305125 http://dx.doi.org/10.1016/j.ekir.2020.09.019 |
Ejemplares similares
-
Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies
por: Rudnicki, Michael
Publicado: (2017) -
Diagnostic and Prognostic Comparison of Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3 Glomerulopathy
por: Kovala, Marja, et al.
Publicado: (2023) -
Long-term Eculizumab Therapy in a Child With Refractory Immune Complex–Mediated Membranoproliferative Glomerulonephritis
por: Chanchlani, Rahul, et al.
Publicado: (2017) -
C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy
por: Garam, Nóra, et al.
Publicado: (2019) -
CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis
por: Piras, Rossella, et al.
Publicado: (2021)